WO2001073059A3 - 38692 and 21117: dual specificity phosphatase molecules and uses therefor - Google Patents
38692 and 21117: dual specificity phosphatase molecules and uses therefor Download PDFInfo
- Publication number
- WO2001073059A3 WO2001073059A3 PCT/US2001/009477 US0109477W WO0173059A3 WO 2001073059 A3 WO2001073059 A3 WO 2001073059A3 US 0109477 W US0109477 W US 0109477W WO 0173059 A3 WO0173059 A3 WO 0173059A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- nucleic acid
- acid molecules
- dual specificity
- specificity phosphatase
- molecules
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
Abstract
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP01922645A EP1319078A2 (en) | 2000-03-24 | 2001-03-23 | 38692 and 21117: dual specificity phosphatase molecules and uses therefor |
AU2001249423A AU2001249423A1 (en) | 2000-03-24 | 2001-03-23 | 38692 and 21117, novel dual specificity phosphatase molecules and uses therefor |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US19185800P | 2000-03-24 | 2000-03-24 | |
US60/191,858 | 2000-03-24 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2001073059A2 WO2001073059A2 (en) | 2001-10-04 |
WO2001073059A3 true WO2001073059A3 (en) | 2002-06-20 |
Family
ID=22707181
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2001/009603 WO2001073060A2 (en) | 2000-03-24 | 2001-03-22 | 18221, dual specificity phosphatase and uses thereof |
PCT/US2001/009477 WO2001073059A2 (en) | 2000-03-24 | 2001-03-23 | 38692 and 21117: dual specificity phosphatase molecules and uses therefor |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2001/009603 WO2001073060A2 (en) | 2000-03-24 | 2001-03-22 | 18221, dual specificity phosphatase and uses thereof |
Country Status (4)
Country | Link |
---|---|
US (2) | US20020065406A1 (en) |
EP (2) | EP1268818A2 (en) |
AU (2) | AU2001247782A1 (en) |
WO (2) | WO2001073060A2 (en) |
Families Citing this family (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6479270B1 (en) * | 2000-02-14 | 2002-11-12 | Pe Corporation (Ny) | Isolated human phosphatase proteins, nucleic acid molecules encoding human phosphatase proteins, and uses thereof |
WO2002026997A2 (en) * | 2000-09-26 | 2002-04-04 | Ceptyr, Inc. | Dsp-16 dual-specificity phosphatase |
DE10056802B4 (en) * | 2000-11-14 | 2005-06-16 | Epigenomics Ag | Method for the detection of methylation conditions for toxicological diagnostics |
US7153678B2 (en) | 2000-12-20 | 2006-12-26 | Bristol-Myers Squibb | Polynucleotides encoding the novel human phosphatase, RET31, and variants thereof |
AU2003271656A1 (en) * | 2002-09-27 | 2004-04-19 | Develogen Aktiengesellschaft Fur Entwicklungsbiologische Forschung | Skrp, astray, string, vacm associated with metabolic control |
US7807849B2 (en) | 2004-04-22 | 2010-10-05 | Commonwealth Scientific And Industrial Research Organisation | Synthesis of long-chain polyunsaturated fatty acids by recombinant cells |
CA3056163C (en) | 2004-04-22 | 2021-04-06 | Commonwealth Scientific And Industrial Research Organisation | Synthesis of long-chain polyunsaturated fatty acids by recombinant cells |
EP2290071B1 (en) * | 2004-05-28 | 2014-12-31 | Asuragen, Inc. | Methods and compositions involving microRNA |
PL2302055T3 (en) | 2004-11-12 | 2015-02-27 | Asuragen Inc | Methods and compositions involving miRNA and miRNA inhibitor molecules |
CN101578363A (en) | 2006-08-29 | 2009-11-11 | 联邦科学技术研究组织 | Synthesis of fatty acids |
WO2008036765A2 (en) * | 2006-09-19 | 2008-03-27 | Asuragen, Inc. | Micrornas differentially expressed in pancreatic diseases and uses thereof |
AU2007299748A1 (en) * | 2006-09-19 | 2008-03-27 | Asuragen, Inc. | miR-15, miR-26, miR -31,miR -145, miR-147, miR-188, miR-215, miR-216 miR-331, mmu-miR-292-3p regulated genes and pathways as targets for therapeutic intervention |
CN101627121A (en) * | 2006-12-08 | 2010-01-13 | 奥斯瑞根公司 | As the miRNA regulatory gene and the path for the treatment of the target of intervening |
WO2008073920A2 (en) * | 2006-12-08 | 2008-06-19 | Asuragen, Inc. | Mir-21 regulated genes and pathways as targets for therapeutic intervention |
AU2007333109A1 (en) * | 2006-12-08 | 2008-06-19 | Asuragen, Inc. | Functions and targets of let-7 micro RNAs |
CA2671270A1 (en) * | 2006-12-29 | 2008-07-17 | Asuragen, Inc. | Mir-16 regulated genes and pathways as targets for therapeutic intervention |
US20090232893A1 (en) * | 2007-05-22 | 2009-09-17 | Bader Andreas G | miR-143 REGULATED GENES AND PATHWAYS AS TARGETS FOR THERAPEUTIC INTERVENTION |
US20090131354A1 (en) * | 2007-05-22 | 2009-05-21 | Bader Andreas G | miR-126 REGULATED GENES AND PATHWAYS AS TARGETS FOR THERAPEUTIC INTERVENTION |
WO2008154333A2 (en) * | 2007-06-08 | 2008-12-18 | Asuragen, Inc. | Mir-34 regulated genes and pathways as targets for therapeutic intervention |
US8361714B2 (en) | 2007-09-14 | 2013-01-29 | Asuragen, Inc. | Micrornas differentially expressed in cervical cancer and uses thereof |
US20090186015A1 (en) * | 2007-10-18 | 2009-07-23 | Latham Gary J | Micrornas differentially expressed in lung diseases and uses thereof |
US8071562B2 (en) * | 2007-12-01 | 2011-12-06 | Mirna Therapeutics, Inc. | MiR-124 regulated genes and pathways as targets for therapeutic intervention |
US20090192114A1 (en) * | 2007-12-21 | 2009-07-30 | Dmitriy Ovcharenko | miR-10 Regulated Genes and Pathways as Targets for Therapeutic Intervention |
US20090263803A1 (en) * | 2008-02-08 | 2009-10-22 | Sylvie Beaudenon | Mirnas differentially expressed in lymph nodes from cancer patients |
US20090233297A1 (en) * | 2008-03-06 | 2009-09-17 | Elizabeth Mambo | Microrna markers for recurrence of colorectal cancer |
WO2009154835A2 (en) * | 2008-03-26 | 2009-12-23 | Asuragen, Inc. | Compositions and methods related to mir-16 and therapy of prostate cancer |
WO2009137807A2 (en) | 2008-05-08 | 2009-11-12 | Asuragen, Inc. | Compositions and methods related to mirna modulation of neovascularization or angiogenesis |
US20100179213A1 (en) * | 2008-11-11 | 2010-07-15 | Mirna Therapeutics, Inc. | Methods and Compositions Involving miRNAs In Cancer Stem Cells |
ES2644883T3 (en) | 2008-11-18 | 2017-11-30 | Commonwealth Scientific And Industrial Research Organisation | Enzymes and methods to produce omega-3 fatty acids |
WO2013040251A2 (en) | 2011-09-13 | 2013-03-21 | Asurgen, Inc. | Methods and compositions involving mir-135b for distinguishing pancreatic cancer from benign pancreatic disease |
SG11201408362SA (en) | 2012-06-15 | 2015-01-29 | Commw Scient Ind Res Org | Production of long chain polyunsaturated fatty acids in plant cells |
CA2933909A1 (en) | 2013-12-18 | 2015-06-25 | Grains Research And Development Corporation | Lipid comprising long chain polyunsaturated fatty acids |
CA2953008C (en) | 2014-06-27 | 2024-03-19 | Nuseed Pty Ltd | Lipid comprising docosapentaenoic acid |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1999002704A2 (en) * | 1997-07-08 | 1999-01-21 | Cold Spring Harbor Laboratory | Dual specifically phosphatase and methods of use |
WO2001020004A2 (en) * | 1999-09-15 | 2001-03-22 | Incyte Genomics, Inc. | Protein phosphatase and kinase proteins |
WO2001046394A2 (en) * | 1999-12-21 | 2001-06-28 | Sugen, Inc. | Mammalian protein phosphatases |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9516059D0 (en) * | 1995-08-04 | 1995-10-04 | Medical Res Council | Novel genes and proteins |
CA2296792A1 (en) | 1999-02-26 | 2000-08-26 | Genset S.A. | Expressed sequence tags and encoded human proteins |
WO2000060099A1 (en) * | 1999-04-07 | 2000-10-12 | Ceptyr, Inc. | Dsp-4 dual-specificity map kinase phosphatase |
WO2001012819A2 (en) * | 1999-08-13 | 2001-02-22 | Sugen, Inc. | Protein phosphatases and diagnosis and treatment of phosphatase-related disorders |
-
2001
- 2001-03-22 AU AU2001247782A patent/AU2001247782A1/en not_active Abandoned
- 2001-03-22 US US09/815,419 patent/US20020065406A1/en not_active Abandoned
- 2001-03-22 EP EP01920760A patent/EP1268818A2/en not_active Withdrawn
- 2001-03-22 WO PCT/US2001/009603 patent/WO2001073060A2/en active Application Filing
- 2001-03-23 EP EP01922645A patent/EP1319078A2/en not_active Withdrawn
- 2001-03-23 AU AU2001249423A patent/AU2001249423A1/en not_active Abandoned
- 2001-03-23 WO PCT/US2001/009477 patent/WO2001073059A2/en not_active Application Discontinuation
- 2001-03-23 US US09/816,494 patent/US6664089B2/en not_active Expired - Fee Related
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1999002704A2 (en) * | 1997-07-08 | 1999-01-21 | Cold Spring Harbor Laboratory | Dual specifically phosphatase and methods of use |
WO2001020004A2 (en) * | 1999-09-15 | 2001-03-22 | Incyte Genomics, Inc. | Protein phosphatase and kinase proteins |
WO2001046394A2 (en) * | 1999-12-21 | 2001-06-28 | Sugen, Inc. | Mammalian protein phosphatases |
Non-Patent Citations (5)
Title |
---|
CAMPS MONTSERRAT ET AL: "Dual specificity phosphatases: A gene family for control of MAP kinase function", FASEB JOURNAL, FED. OF AMERICAN SOC. FOR EXPERIMENTAL BIOLOGY, BETHESDA, MD, US, vol. 14, no. 1, January 2000 (2000-01-01), pages 6 - 16, XP002160024, ISSN: 0892-6638 * |
DATABASE EMBL 11 May 1999 (1999-05-11), STRAUSBERG, R.: "tu08d11.x1 NCI_CGAP_Pr28 Homo sapiens cDNA clone IMAGE:2250453 3', mRNA sequence.", XP002176720 * |
DATABASE EMBL 24 May 1999 (1999-05-24), MUNZY, D.M. ET AL.: "Homo sapiens 12p BAC RP11-253I19 (Roswell Park Cancer Institute Human BAC", XP002176719 * |
NAGASE T, KIKUNO R, HATTORI A, KONDO Y, OKUMURA K, OHARA O.: "Prediction of the coding sequences of unidentified human genes. XIX. The complete", DNA RESEARCH, vol. 7, no. 6, 31 December 2000 (2000-12-31), pages 347 - 55, XP001016382 * |
TANOUE TAKUJI ET AL: "Molecular cloning and characterization of a novel dual specificity phosphatase, MKP-5", JOURNAL OF BIOLOGICAL CHEMISTRY, AMERICAN SOCIETY OF BIOLOGICAL CHEMISTS, BALTIMORE, MD, US, vol. 274, no. 28, 9 July 1999 (1999-07-09), pages 19949 - 19956, XP002148678, ISSN: 0021-9258 * |
Also Published As
Publication number | Publication date |
---|---|
EP1319078A2 (en) | 2003-06-18 |
US6664089B2 (en) | 2003-12-16 |
AU2001247782A1 (en) | 2001-10-08 |
WO2001073059A2 (en) | 2001-10-04 |
US20020034807A1 (en) | 2002-03-21 |
AU2001249423A1 (en) | 2001-10-08 |
EP1268818A2 (en) | 2003-01-02 |
WO2001073060A2 (en) | 2001-10-04 |
WO2001073060A3 (en) | 2002-04-04 |
US20020065406A1 (en) | 2002-05-30 |
WO2001073060A9 (en) | 2002-12-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2001073059A3 (en) | 38692 and 21117: dual specificity phosphatase molecules and uses therefor | |
WO2001090325A3 (en) | 50365, a hexokinase family member and uses thereof | |
WO2002006302A3 (en) | 16816 and 16839, novel human phospholipase c molecules and uses therefor | |
WO2002006330A3 (en) | 13237,18480,2245 or 16228 human protein kinase molecules and uses therefor | |
WO2002026803A3 (en) | 22108 and 47916, novel human thioredoxin family members and uses thereof | |
WO2001094390A3 (en) | 52906, 33408, and 12189, potassium channel family members and uses thereof | |
WO2001064904A3 (en) | 25324, 50287, 28899, 47007, and 42967 transferase family members and uses therefor | |
WO2001066765A3 (en) | 26583, a serine/threonine phosphatase and uses thereof | |
WO2001083719A3 (en) | 25692, a novel human o-methyltransferase family member and uses thereof | |
WO2001094563A3 (en) | 46980, a novel human neuroligin family member and uses thereof | |
WO2001075076A3 (en) | 33167, a novel human hydrolase and uses therefor | |
WO2001064905A3 (en) | 2504, 15977, and 14760, novel protein kinase family members and uses therefor | |
WO2001066764A3 (en) | 16835, a human phospholipase c and uses thereof | |
WO2002020801A3 (en) | 26199, 33530, 33949, 47148, 50226, and 58764, human transferase family members and uses therefor | |
WO2002000863A3 (en) | 32140, a novel human aldehyde dehydrogenase and uses therefor | |
WO2002018439A3 (en) | 52991, a human transporter protein and uses therefor | |
WO2001090145A3 (en) | 57805, a human cadherin family member and uses thereof | |
WO2001073051A3 (en) | 46743 and 27417, novel human acyltransferase family members and uses therefor | |
WO2002038773A3 (en) | A human phospholipase c and uses thereof | |
WO2002029037A3 (en) | 57800, a novel human cadherin and uses therefor | |
WO2002010401A3 (en) | 18431 and 32374, human protein kinase family members and uses therefor | |
WO2002006331A3 (en) | 14087, a serine protease molecule and uses therefor | |
WO2002029040A3 (en) | 25219, a novel human aminotransferase and uses therefor | |
WO2002008400A3 (en) | 25233, a human aminotransferase and uses therefor | |
WO2002051991A3 (en) | 17903, a human aminopeptidase and uses therefor |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2001922645 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 2001922645 Country of ref document: EP |
|
NENP | Non-entry into the national phase |
Ref country code: JP |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 2001922645 Country of ref document: EP |